Retractable Technologies (RVP) Cash from Financing Activities (2010 - 2026)
Retractable Technologies (RVP) posted Cash from Financing Activities of -$146823.0 for Q1 2026, down 1.49% on a QoQ basis from -$144673.0 in Q4 2025, and down 5.23% year-over-year from -$154924.1 in Q1 2025.
Retractable Technologies (RVP) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Retractable Technologies' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$146823.0 for Q1 2026.
- Quarterly Cash from Financing Activities fell 5.23% year-over-year to -$146823.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$574617.0 (down 5.69% YoY) and the FY2025 annual result came in at -$567321.0, down 5.96% from the prior year.
- Cash from Financing Activities was -$146823.0 for Q1 2026 at Retractable Technologies, down from -$144673.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $4.7 million in Q3 2022 and bottomed at -$2.8 million in Q4 2022.
- A 5-year average of $275598.9 and a median of -$134252.0 in 2024 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 95.1% in 2023, while the deepest fall reached 4922.48% in 2023.
- Retractable Technologies' Cash from Financing Activities stood at -$2.8 million in 2022, then soared by 95.1% to -$136357.0 in 2023, then declined by 0.47% to -$136996.0 in 2024, then slipped by 5.6% to -$144673.0 in 2025, then retreated by 1.49% to -$146823.0 in 2026.
- Business Quant data shows RVP's Cash from Financing Activities at -$146823.0 in Q1 2026, -$144673.0 in Q4 2025, and -$142396.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Retractable Technologies | 20.36 Mn | -15.26 Mn | -838,408.00 | -146,823.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,823.00 |
| Mar 31, 2026 | -146,823.00 |
| Dec 31, 2025 | -144,673.00 |
| Dec 31, 2025 | -144,673.00 |
| Sep 30, 2025 | -142,396.00 |
| Sep 30, 2025 | -142,396.00 |
| Jun 30, 2025 | -140,725.00 |
| Jun 30, 2025 | -140,725.00 |
| Mar 31, 2025 | -139,527.00 |
| Mar 31, 2025 | -139,527.00 |
| Dec 31, 2024 | -136,996.00 |
| Dec 31, 2024 | -136,996.00 |
| Sep 30, 2024 | -134,252.00 |
| Sep 30, 2024 | -134,252.00 |
| Jun 30, 2024 | -132,926.00 |
| Jun 30, 2024 | -132,926.00 |
| Mar 31, 2024 | -131,259.00 |
| Mar 31, 2024 | -131,259.00 |
| Dec 31, 2023 | -136,357.00 |
| Dec 31, 2023 | -136,357.00 |